Contact us</a> to connect your oncology program with solutions to support your success.</p>" /> Contact us</a> to connect your oncology program with solutions to support your success.</p>" />
Article
Cell and Gene R&D in Cancer Care: Increasing Patient Access
Oct 06, 2022
Download

Published in Contract Pharma September 2022

With more than $185 billion in global investment in research and development, global oncology drug development is leading the way in clinical trial activity and in the launch of novel medicines. In addition to the emphasis on survival, stakeholders are focused on improving the current quality of life for patients and strengthening the overall cancer care paradigm. In this article, read about the latest in CAR-T therapies, dose optimization in early phase oncology trials, and operational considerations for clinical trials.

Contact us to connect your oncology program with solutions to support your success.

Related solutions

Contact Us